Eli Lilly (LLY) reported Q4 non-GAAP earnings Thursday of $5.32 per diluted share, up from $2.49 a year earlier.
Analysts polled by FactSet expected $5.01.
Revenue for the quarter ended Dec. 31 was $13.53 billion, up from $$9.35 billion a year earlier.
Analysts surveyed by FactSet expected $13.53 billion.
For 2025, the company said it expects non-GAAP EPS of $22.50 to $24 on revenue of $58 billion to $61 billion.
Analysts polled by FactSet expect non-GAAP EPS of $22.76 on $58.77 billion in revenue.
The company's shares were up nearly 3% in recent Thursday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.